Martin Makary, President Donald Trump's nominee to run the U.S. FDA, on Thursday promised to convene the agency's vaccine advisory committee, but did not commit to rescheduling a canceled meeting to discuss the composition of the next seasonal flu vaccine.

Senators asked Makary about the FDA’s decision to cancel a scheduled meeting of its outside committee of vaccine experts to discuss the design of this year’s influenza vaccine